Janssen loses patent dispute

Published: 2007-02-05 06:56:00

Updated: 2007-02-05 06:56:00

The Seoul High Court on January 18 upheld a lower court ruling that dismissed a claim from Belgium-based Janssen Pharm that Whanin Pharm's Riperidone (risperidone) had
infringed on its patent.

Janssen first filed a lawsuit against Whanin on August 2003, claiming that the Korean company's man...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK